RATIONALE: There is evidence that symptoms and treatment responses for children and adults with eosinophilic esophagitis (EoE) differ. However, there are a lack of prospective studies describing the transition period from pediatric to adult care for EoE. We extended our BC Children's Hospital (BCCH) EoE registry to include patients who graduated to adult care at St. Paul's Hospital (SPH), to better understand the transition process and natural history of EoE. METHODS: Patients who had a biopsy-proven diagnosis, were part of the BCCH registry, and were subsequently seen at SPH were included in this chart review. Symptom pattern and management changes were captured. RESULTS: 169 patients were enrolled in our registry. 7/169 transitioned to SPH. 6/7 consented to this study. Between their last BCCH and first SPH visit [median interval 5 12.5mo; IQR (10, 18)], 3/6 who previously experienced dysphagia, abdominal pain, chest pain, and/or excessive chewing became asymptomatic. 1/6 experienced fewer symptoms at SPH (from dysphagia, food impaction, heartburn at BCCH to only heartburn at SPH). None experienced an increased number of symptoms. 4/6 were treated medically at BCCH. At SPH, 2/4 stopped and 2/4 changed medications. 4/6 underwent dietary elimination at BCCH; 3/4 eliminated milk. At SPH, 3/3 continued eliminating milk; 1/3 additionally eliminated egg and wheat. CONCLUSIONS: We observed changes in symptoms and treatment sooner than expected in a median 12.5-month interval. However, these preliminary data are from patients successfully transitioned to adult care, which may not represent those lost to follow-up, a group we are contacting to learn about their transition. RATIONALE: Existing studies in pediatric eosinophilic esophagitis (EoE) suggest that psychosocial dysfunction is common. We measured the prevalence of psychiatric diagnoses in a large EoE cohort and explored relationships with other disease factors. METHODS: Data on demographics, allergic history, symptoms, psychiatric diagnoses, medications, and outcomes were obtained by retrospective chart review of pediatric EoE patients newly diagnosed during the past two years (n5351). RESULTS: Patients reported anxiety (n5 75[21%]), attention deficit hyperactivity disorder (ADHD) (n559[17%]), depression (n533[9.3%]), and autism (n514[3.9%]). Because it was most common, we compared EoE patients with anxiety to those with no anxiety (NA group, n5276). Among patients with anxiety, 39% were seen by a psychologist and 32% were taking medicine for anxiety. Similar to NA patients, 40% with anxiety were female and 93% were white. Patients with anxiety were older (13 years [range 2-19] vs 11 years [0.4-22], p50.010). Symptoms of pain (p50.004), vomiting (p50.048), and GER (p50.044) were significantly more common in patients with anxiety than NA, while food impactions (15 and 20%, p50.17) and dysphagia (50 and 48%, p50.56) were similar in the groups. There were no significant differences in peak eosinophil counts or concurrent allergic diagnoses including food allergy and anaphylaxis. The majority of patients were treated with swallowed fluticasone (95% [anxiety] and 90% [NA] ), and the rates of histologic remission were similar (50% and 45% respectively [p50.61]). CONCLUSIONS: Anxiety was commonly reported by EoE patients and was not related to food allergies or treatment. Comprehensive care for EoE patients should include screening for mental health conditions.
